Matéria de Kerry Cullinan no site da Health Policy Watch resume a consulta informal que o Órgão Intergovernamental de Negociação (OIN) realizou em outubro sobre temas de propriedade intelectual relacionados ao acordo sobre pandemias, apontando divergências entre os especialistas consultados.
Segundo a OMS, participaram do painel os seguintes especialistas convidados:
- Richard Hatchett, CEO, Coalition for Epidemic Preparedness Innovations (CEPI)
- Carlos Correa, Executive Director of South Centre
- Padmashree Gehl Sampath, Fellow and Senior Advisor, Global Access in Action Program, Berkman Klein Center, Harvard University and Chair Person, Technical Advisory Group of COVID-19 Technology Access Pool (CTAP)
- Ellen ‘t Hoen, Director, Medicines Law & Policy / Global Health Law Fellow Law Faculty, University of Groningen, Netherlands
- Komal Kalha, Associate Director, Intellectual Property & Trade Policy, International Federation of Pharmaceutical Manufacturers and Associations
- Mojisera Adeyeye, Director-General National Agency for Food and Drug Administration and Control in Nigeria (NAFDAC), Nigeria
- Martin Harvey Allchurch, Head of International Affairs, European Medicines Agency
Pelo Secretariado da OMS, participaram:
- Soumya Swaminathan, Chief Scientist
- Mariângela Simão, WHO Assistant Director-General, Access to Medicines and Health Products
